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background:  The role of racial difference in predicting downstream cardiac costs after stress echocardiography (SE) is poorly understood.
methods:  Medicare beneficiaries who had a complete treadmill SE performed at the Cleveland Clinic from 2002-08 were linked to Medicare claim 
files and 2 year downstream cardiac costs (including inpatient, out patient, and professional charges) were calculated. We examined adjusted cost 
using general linear modeling to determine whether racial differences still exist after accounting for clinical and demographic variables.
results:  Of a sample population of 3,791 (mean age 72±5 yrs., 63% men), 89% were of white race with 11% non-white (7% African American, 
4% Hispanic, Asian, or Other). Although the breakdown of test result was not different between groups, non-white patients had a significantly higher 
rate of smoking, hypertension, diabetes, renal dysfunction and adverse socioeconomic indicators. Total cardiac charges were 31% less for non-white 
enrollees ($5,656) vs. white enrollees ($8,159). In multivariate analysis, race was a significant predictor of downstream two year costs (p=0.007). Of 
note, there was no difference in death rate by race (11% white, 9% non-white; p=0.57) after adjustment for known risk factors.
conclusions:  Despite access to care in a Medicare population, race significantly impacts downstream 2 year cardiac costs following SE. Non-
white patients have significantly lower costs despite higher clinical and socioeconomic risk factors.
 
